AEON stock

AEON Biopharma, Inc. (AEON) financials · P/E 0.0, $8.6M cap

AEON Biopharma, Inc. (AEON) P/E 0.0, $8.6M cap.

Cached annual income statement
LineFY2025
Revenue$0
Cost of Revenue$0
Gross Profit$0
Operating Income-$12.8M
Net Income-$39.2M
EPS (Diluted)$-3.95
Cached annual balance sheet
LineFY2025FY2024
Total Assets$5.6M$3.1M
Current Assets$3.4M$1.6M
Cash & Equivalents$3.0M$13.0K
Inventory$0$0
PP&E$162.0K$235.0K
Total Liabilities$60.6M$31.7M
Current Liabilities$6.9M$14.1M
Short-term Debt$0$0
Long-term Debt$0$0
Total Debt$0$0
Shareholders' Equity-$55.0M-$28.6M
Retained Earnings-$470.8M-$431.6M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$17.3M-$20.3M
CapEx$4.0K$0
Investing Cash Flow-$4.0K$0
Financing Cash Flow$20.3M$15.1M
Dividends Paid$0$0
Net Change in Cash$3.0M-$5.1M
Free Cash Flow-$17.3M$0

FAQ

What is AEON P/E and revenue?

AEON Biopharma, Inc. (AEON) P/E 0.0, $8.6M cap.

What is AEON revenue?

AEON Biopharma, Inc. last cached revenue is $0 (FY2025).

Is AEON profitable?

AEON Biopharma, Inc. last cached net income is -$39.2M.

What are AEON total assets?

AEON Biopharma, Inc. last cached total assets are $5.6M.

What is AEON free cash flow?

AEON Biopharma, Inc. last cached free cash flow is -$17.3M.

Not investment advice. Cached statements, not a live tape.